Stock AVBP ARRIVENT BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights ArriVent BioPharma, Inc.

Equities

AVBP

US04272N1028

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-20 EDT 		5-day change 1st Jan Change
16.6 USD -5.20% Intraday chart for ArriVent BioPharma, Inc. -11.84% 0.00%
06-05 ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment MT
06-05 Alphamab Strikes Deal with Nasdaq-Listed ArriVent to Co-Develop Antibody Drug Conjugates MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment
MT
Alphamab Strikes Deal with Nasdaq-Listed ArriVent to Co-Develop Antibody Drug Conjugates
MT
Jiangsu Alphamab Biopharmaceuticals Co., Ltd. Enters into Research and Collaboration Agreement with Arrivent Biopharma, Inc
CI
ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
ArriVent BioPharma, Inc. has completed an IPO in the amount of $174.999996 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVBP Stock
  4. News ArriVent BioPharma, Inc.
  5. Highlights